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Abstract 
Purpose: To investigate whether two synthetic prenylated xanthone analogues - 1,3,6,8-tetrahydroxy-
9H-xanthen-9-one (SX1) and 1,3,6-trihydroxy-2-(3-methylbut-2-enyl)-9H-xanthen-9-one (SX2) - are 
potential candidates for neuroprotection against paraquat- and 6-hydroxydopamine (OHDA)-induced 
human neuroblastoma SH-SY5Y cell death.  
Methods: SH-SY5Y cells were treated with SX1 and SX2, and the maximum non-toxic dose (MNTD) 
were obtained by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. MTT assay 
was also used to assess the ability of MNTD and half MNTD (HMNTD) doses of SX1 and SX2 to protect 
against the neurotoxicity of 200 µM paraquat and 100 µM 6-OHDA. Intracellular ROS production by SH-
SY5Y cells treated or untreated with SX1 or SX2 was measured by dichloro-dihydro-fluorescein 
diacetate (DCFH-DA) assay. 
Results: SX1 and SX2 MNTDs at concentrations of 1850 nM and 105 nM, respectively, did not 
significantly (p > 0.05) provide neuroprotection against paraquat-induced SH-SY5Y cell death. Only SX2 
MNTD and HMNTD significantly (p < 0.05) protected SH-SH5Y cells against 6-OHDA-induced cell death 
by 10 and 17 % improved cell viability. Although intracellular ROS production was significantly 
attenuated by SX1 HMNTD and MNTD, this did not improve cell viability against paraquat-induced cell 
death.  
Conclusion: These results reveal that SX2 confers neuroprotection on 6-OHDA-induced SH-SY5Y 
neurotoxicity. Further investigations to elucidate the detailed molecular mechanisms of neuroprotection 
by SX2 are warranted. 
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Paraquat and 6-hydroxydopamine (6-OHDA) 
have been used in the laboratory as prototypical 
neurotoxins to induce neurodegeneration in both 
in vivo and in vitro settings. 6-OHDA induces 
neurotoxicity by producing hydrogen peroxide, 
superoxide radical, oxidized glutathione and 
hydroxyl radical during its autoxidation [1]. These 
oxidative stresses may ultimately result in 
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neurodegeneration by inducing inflammation of 
neurons and death of neurons in the brain [2]. 
Paraquat has been considered as a possible 
etiologic factor in Parkinson's disease. Divalent 
paraquat ion (PQ2+) in brain is reduced to 
monovalent paraquat ion (PQ+) by extracellular 
enzymes such as NADPH-oxidase in microglia, 
which then serves as a dopamine transporter 
substrate [3]. Subsequently, PQ+ accumulates in 
dopaminergic neurons and reestablishes a new 
redox reaction intracellularly, leading to the 
generation of intracellular free radicals such as 
superoxide and dopamine reactive substances. 
This will eventually lead to dopaminergic neuron 
cell death as seen in Parkinson’s disease [3].  
 
Several phytochemicals including fatty acids, 
phenols, flavonoids, saponins, xanthones and 
terpenes found in natural products are potential 
neuroprotective compounds due to their anti-
oxidation and anti-lipid peroxidation activities [4]. 
Natural or synthetic xanthones, in view of their 
unique structural chromophore, have been 
reported to exhibit a wide range of biological 
properties including cytotoxicity, anti-
inflammatory, antioxidant, antimalarial, 
antibacterial and antifungal activities [5]. Our 
previous studies showed that certain synthetic tri- 
and tetra-oxygenated prenylated xanthones had 
cytotoxic activities against cervical and breast 
cancer cell lines [6,7]. A recent finding showed 
that six newly isolated prenylated xanthones from 
ethyl acetate soluble extract of Cudrania 
tricusidata root bark together with six previously 
identified prenylated xanthones had 
neuroprotective effects against 6-OHDA-induced 
cell death in human neuroblastoma SH-SY5Y 
cells [8]. This provides an early finding that 
prenylated xanthones could have neuroprotective 
property against certain drugs or chemicals that 
induce neurodegeneration like paraquat and 6-
OHDA.  
 
Therefore, the objective of this study was to 
evaluate the neuroprotective property of two 
selected synthetic prenylated xanthone 
analogues from our previous studies [6,7], 
against the toxicities of paraquat and 6-
hydroxydopamine in a dopaminergic cell line - 






Two selected prenylated xanthone analogues 
were from our previous studies  1,3,6-trihydroxy-
9H-xanthen-9-one (SX1) is compound 1 in [6] 
and 1,3,6-trihydroxy-2-(3-methylbut-2-enyl)-9H-
xanthen-9-one (SX2) is compound 8 in [7]. The 
structures are shown in Figure 1 and the 
synthesis processes were as outlined in our 
previous studies [6,7]. These compounds were 
selected as they have IC50 of > 60 μM in human 
breast cancer MDA-MB-231 cell line [6,7]. A 
higher IC50 of a compound would enable a wider 
range of dosages to be tested on SH-SY5Y 





Human neuroblastoma SH-SY5Y (ATCC® CRL-
2266™) was obtained from the American Type 
Culture Collection (Manassas, VA, U.S.A.). The 
cells were maintained in Dulbecco’s Modified 
Eagle’s Medium (DMEM; Thermo Fischer 
Scientific PA, USA) containing 10 % Fetal Bovine 
Serum (FBS; Sigma-Aldrich, MO, USA) and 1 % 
penicillin-streptomycin (Nacalai Tesque, Japan) 




Figure 1: Structures and molecular weights of two selected prenylated xanthone analogues used in this study. 
Their codes and molecular weight (g/mol) are as indicated 
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Determination of maximum non-toxic dose 
(MNTD) by MTT assay and treatment 
paradigm 
 
SH-SY5Y human neuroblastoma cells were 
seeded in 96-well plates at a cell density of 8,000 
cells/well in 100 µL of complete growth. Upon 
attachment the next day, the cells were replaced 
with serum-free medium (basic medium) on next 
day for another 24 h to synchronize the growth 
stage of cells. On the third day, the cells were 
treated with synthetic prenylated xanthones SX1 
and SX2 dissolved in dimethyl sulfoxide (DMSO), 
at a range of concentrations from 0 to 5000 nM 
by two-fold dilution, for 48 h.  
 
Cells were then rinsed twice with phosphate 
buffer saline (PBS) and 20 μL of 3-(4,5-
dimethylthiazol-2-yl)-2.5-diphenyltetrazolium 
bromide (MTT) reagent (Bio Basic Canada Inc., 
Canada) stock solution (5 mg/mL) was then 
added to each well. The cells were then 
incubated at 37 ºC for 4 h, before 100 µL of 
DMSO was added to solubilize the purple 
formazan crystals. After an hour of incubation, 
the absorbance was measured at the wavelength 
of 570 nm using a microplate reader (M200 
Tecan, Switzerland). To determine the MNTD or 
½ MNTD of SX1 and SX2, a graph of percentage 
of toxicity against the log10 concentration of 
compounds was plotted. MNTD was determined 
at the first x-intercept where the toxicity is 0 %, 
while half MNTD (HMNTD) was half of the MNTD 
selected.  
 
For the determination of neuroprotection against 
paraquat and 6-OHDA-induced cell death, SH-
SY5Y cells were grown at 8,000 cells/well, 
cultured and starved as mentioned above. On 
the third day, the cells were incubated with SX1 
and SX2 at their MNTDs and HMNTDs for 24 h. 
On the fourth day, the cells were treated with 200 
µM paraquat (stock solution dissolved in filter 
sterilized deionized water) or 100 µM 6-OHDA 
(stock solution dissolved in filter sterilized 
deionized water and supplemented with 0.02 % 
of ascorbic acid and 0.85 % of NaCl) in complete 
growth medium for another 24 h.  
 
MTT assay was then performed as per described 
above and graphs of percentage cell viability vs. 
treatments were plotted. Growth control was 
represented by cells that were cultured with only 
the medium while the positive control of 
neuroprotection was represented by the addition 
of D-α-tocopherol (vitamin E; an antioxidant) 
during the treatment with paraquat or 6-OHDA. 
 
Determination of intracellular free radical 
production by dichloro-dihydro-fluorescein 
diacetate (DCFH-DA) assay 
 
SH-SY5Y cells were grown at similar density, 
cultured and starved as mentioned above. On 
the third day, the medium was removed from 
each well and cells were rinsed with PBS twice. 
Then the cells were incubated with 100 µM of 
DCFH-DA (stock solution dissolved in filter 
sterilized deionized water) in complete growth 
medium at 37 °C in 5 % CO2 humidified 
incubator for 30 min. The growth medium 
containing DCFH-DA was then removed by 
pipetting, and the cells were rinsed twice with 
PBS and incubated with 200 µM paraquat or 100 
µM 6-OHDA together with the presence or 
absence of SX1 and SX2 MNTD. Immediately, 
fluorescence was measured at 485 nm excitation 
wavelength and 530 nm emission wavelength 
using a microplate reader (M200, Tecan, 
Switzerland). The readings were taken every 10 
min for 30 min and last reading was taken at 60 
min of incubation time. The fluorescence 
readings were expressed in percentage change 
in fluorescence intensity compared with wells 




Data was expressed as mean ± standard error of 
the mean (SEM) of at least two independent 
experiments, which were performed in replicates 
as stated in the figure legends. Statistical 
analysis was performed using Student’s t-test for 
comparison between means of two continuous 
variables using IBM SPSS Statistics software 
version 16.0 (IBM, NY, USA). A p-value of less 





Maximum non-toxic dose (MNTD) and half 
maximum non-toxic dose (½ MNTD) 
 
Across the range of dosages of SX1 and SX2 
tested on SH-SY5Y cells, neurotoxicity ranged 
from -3 to 7 % (Figure 2); positive values indicate 
cell death, negative values indicate cell 
proliferation. Cells treated with SX1 showed 
more fluctuations in neurotoxicity across the 
range of dosages tested, while those treated with 
SX2 showed fluctuations above 0 %, starting 
from 100 nM. As determined from the graph, 
MNTDs of SX1 and SX2 were 1850 and 105 nM, 
respectively, while the HMNTDs were 925 and 
52.5 nM, respectively. Overall, the MNTD and 
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HMNTD of SX1 were observed to be 18-fold 
higher than SX2. 
 
Neuroprotection against paraquat- and 6-
OHDA-induced cell death 
 
Treatment with paraquat alone significantly 
induced 21.03 ± 2.82 % of neurotoxicity on SH-
SY5Y cells compared with growth control (Figure 
3A), while treatment with 6-OHDA alone induced 
13.61 ± 2.96 % of neurotoxicity (Figure 3B). Co-
incubation of paraquat with vitamin E (positive 
control for neuroprotection) significantly 
increased the viability of SH-SY5Y cells by nearly 
20 % as compared with cells treated with 
paraquat alone (Figure 3A). Similarly, co-
treatment of  6-OHDA with vitamin E significantly 
increased the viability of SH-SY5Y cells by nearly 
18 % as compared with cells treated with 6-
OHDA alone (Figure 3B). Treatment with MNTDs 
and HMNTDs of SX1 or SX2 alone did not 
significantly increase the cell viability compared 
with the growth control (Figure 3A and Figure 
3B). Co-incubation of MNTDs and HMNTDs of 
SX1 or SX2 with paraquat did not significantly 
protect the cells from neurotoxicity, compared 
with growth control (Figure 3A). However, co-
treatment of MNTDs and HMNTDs of SX2 (but 
not SX1) with 6-OHDA, significantly increased 
the cell viability by 11.55 ± 1.82 and 17.26 ± 1.87 
%, respectively, compared with treatment with 6-
OHDA alone (Fig 3B). This indicates that SX2, 
but not SX1, had significant neuroprotection 
against 6-OHDA neurotoxicity, but not paraquat 
neurotoxicity. 
 
Figure 2: Neurotoxicity of (A) SX1 and (B) SX2 on SH-SY5Y cells after incubation for 48 h, in two fold dilution 
method with the range of 0 to 5000 nM. Data are shown as mean ± SEM of three independent experiments 
performed in five replicates 
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Intracellular reactive oxygen species 
(ROS) production by cells treated with 
paraquat or 6-OHDA 
 
As shown in Fig 4, paraquat treatment alone over 
60 min significantly induced 79.73 ± 4.09 % 
increment in intracellular ROS production in SH-
SY5Y cells compared with untreated growth 
control. Addition of vitamin E (a potent 
antioxidant) to cells treated with paraquat 
significantly attenuated the production of 
intracellular ROS at 20, 30 and 60 min time 
points compared with paraquat treatment alone. 
Intracellular ROS production in cells treated with 
paraquat and SX1 and SX2 MNTDs and 
HMNTDs gradually increased across the time 
points, with SX1 HMNTD showing significances 
across all time points, compared with paraquat 
treatment alone (Fig 4). 
 
 
Figure 3: Effect of SX1 and SX2 treatment on paraquat- and 6-OHDA-induced neurotoxicity in SH-5YSY cells. 
Data are shown as mean ± SEM of three independent experiments performed in eight replicates; *indicates p < 
0.05 compared with growth control while # indicates p < 0.05 compared with paraquat or 6-OHDA treatment 
alone.
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Figure 4: Fluorescence intensity of DCFH-DA upon treatments for 60 min. Data are shown as mean ± SEM of 
two independent experiments performed in six replicates; * p < 0.05 compared with growth control; #p < 0.05 
compared with paraquat treatment alone at the same time points; ##p < 0.01 compared with paraquat or 6-OHDA 
treatment alone 
 
Addition of SX1 HMNTD significantly increased 
ROS production at earlier time points (10, 20, 30 
min), but significantly attenuated approximately 
15 % of intracellular ROS production at 60 min 
time point. SX1 MNTD also significantly did so at 
60 min. However, treatment with SX2 HMNTD 
and MNTD significantly increased ROS 
production at 60 min, instead of decreasing it. 
The co-treatment of 6-OHDA with SX1 and SX2 
HMNTDs and MNTDs produced similar results 
with the treatment with 6-OHDA alone (data not 
shown), indicating that SX1 and SX2 did not 
have any effect in attenuating or increasing 
intracellular ROS production in SH-SY5Y cells 




Previously, it was shown that six newly isolated 
prenylated xanthones from ethyl acetate soluble 
extract of Cudrania tricusidata root bark 
(cudratrixanthone C, cudratrixanthone G, 
cudratrixanthone H, cudratrixanthone I, 
cudratrixanthone O, 3-O-methylcudratrixanthone 
G), and six other previously identified prenylated 
xanthones (cudraxanthone A, 6-deoxyiso-
jacareubin, nigrolineaxanthone F, neriifolone A, 
cudraxanthone L, gerontoxanthone C), protected 
against 6-OHDA-induced cell death in human 
neuroblastoma SH-SH-SY5Y cells [8]. These 
compounds gave the EC50 values of 0.7 – 16.6 
μM, compared with positive control curcumin - 
6.0 μM. In our study, we used a slightly different 
approach in determining the neuroprotective 
property of two selected prenylated xanthones - 
1,3,6-trihydroxy-9H-xanthen-9-one (SX1) and 
1,3,6-trihydroxy-2-(3-methylbut-2-enyl)-9H-
xanthen-9-one (SX2). We determined their 
HMNTDs and MNTDs first before these dosages 
were used to test for potential neuroprotection 
against paraquat and 6-ODHA-induced neuronal 
cell death. Determination of MNTD is crucial prior 
to subsequent neuroprotection assay so that the 
compound would not pose any neurotoxicity 
during treatment. This similar approach of MNTD 
determination first has been used in numerous 
neuroprotection assays of natural products, such 
as orientin [9] and edible bird nest (EBN) extract 
[10].  
 
We found that the neurotoxicity of SX2 was two-
fold more than the neurotoxicity of SX1, while the 
MNTD of SX1 was nearly 17 times higher than 
MNTD of SX2. Orientin, a flavonoid-like 
phytochemical which showed neuroprotection 
against oxidative stress-induced SH-SY5Y cell 
death, had MNTD of 20 µM, which was much 
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higher than the MNTDs of SX1 and SX2 [9]. This 
discrepancy of toxicity profile of SX1 and SX2 is 
also evident in our previous studies, whereby the 
inhibitory concentration (IC50) of SX1 on HeLa 
and MDA-MB-231 were > 60 µM and > 60 µM, 
respectively [6], while IC50 of SX2 on HeLa and 
MDA-MB-231 were 48 µM and > 60 µM, 
respectively [7]. These differences in 
neurotoxicity profile of SX1 and SX2 could be 
due to the different mode of action by distinct 
degree of prenylation of xanthone [11].  
 
Paraquat at 200 µM induced nearly 20 % of SH-
SY5Y neuronal cell death over 24 h of 
incubation, consistent with the results of a 
previous study [12]. Paraquat-induced cell death 
is possibly caused by the oxidative stress 
generated during incubation. Specifically, new 
redox reaction between paraquat radical and 
oxygen generate true reactive oxygen species, 
O2- and H2O2, which significantly cause cell 
death [12,13]. However, 6-OHDA treatment 
caused only around 20 % of neuronal cell death 
compared to ≥50 % at similar concentration, as 
shown in previous studies [14,15]. 6-OHDA is 
prone to oxidation. Therefore, a prolonged 
incubation period of 24 h might have caused the 
6-OHDA to be oxidized and degraded, rendering 
it to be no longer a bioactive neurotoxin [16].  
 
Vitamin E as a lipophilic antioxidant attenuated 
paraquat and 6-OHDA-induced cell death to 
nearly 20 % of improved cell viability in SH-SY5Y 
cells, suggesting that lipid peroxidation plays a 
role in 6-OHDA and paraquat toxicity [17]. The 
co-incubation of paraquat with SX1 and SX2 
HMNTDs and MNTDs did not significantly protect 
the cells against paraquat-induced neurotoxicity. 
In contrast, SX2 HMNTD and MNTD improved 
cell viability of 6-OHDA challenged SH-SY5Y 
cells. The majority of xanthones isolated in a 
previous study have relatively higher dose in 
order to improve cell viability upon introduction of 
neurotoxins, while only minor group of xanthones 
with relatively complex prenylation showed more 
potent neuroprotection at lower dose [8]. This 
suggests that the SX1 and SX2 are not as potent 
as natural xanthones isolated from Cudrania 
tricuspidata as the MNTDs of SX1 and SX2 were 
too low to provide neuroprotection against 
paraquat-induced cell death. 
 
Cells treated with paraquat alone had the 
strongest intracellular ROS production over 60 
min of treatment. This shows that neurotoxic 
paraquat ion (PQ+) accumulated in dopaminergic 
neuron to reestablish a new redox reaction 
intracellularly, leading to generation of 
intracellular free radicals such as superoxide and 
dopamine reactive substances in the neuron [3]. 
The co-incubation of paraquat with vitamin E 
significantly reduced intracellular ROS production 
at time point 10, 20, 30 and 60 minutes as 
compared to incubation with paraquat alone. A 
previous study demonstrated in rodent model 
that vitamin E could strengthen the antioxidative 
defense system with an increased activity of 
antioxidative enzymes, including superoxide 
dismutase (SOD) and glutathione peroxidase 
(GSH-px) [18].  
 
The co-incubation of paraquat with SX1 HMNTD 
and MNTD attenuated intracellular ROS 
production but did not rescue the SH-SY5Y cells 
from paraquat-induced cell death, while SX2 
HMNTD and MNTD maintained increased 
intracellular ROS production. The attenuation of 
intracellular ROS would normally rescue the cell 
from oxidative stress-induced cell death [10]. 
However, this was not observed in this study. 
One of the possible reasons is that the direct free 
radical scavenging did not sufficiently protect 
early apoptotic cells against neurotoxin-induced 
cell death. This indicates that there could other 
mechanisms involved other than direct anti-
oxidation in rescuing paraquat-induced SH-SY5Y 
cell death. This is evident in a previous study, 
where the effective free radical scavenging 
activity of EBN extract did not rescue SH-SY5Y 






xanthen-9-one (SX2) at 105 nM (MNTD) and 
52.5 nM (HMNTD) concentrations successfully 
confer neuroprotection by significantly protecting 
SH-SY5Y cells against 6-OHDA-induced cell 
death by improving 10 and 17 % cell viability. 
Although intracellular ROS production was 
significantly attenuated by 1,3,6-trihydroxy-9H-
xanthen-9-one (SX1) at 1850 nM (MNTD) and 
925 nM (HMNTD) concentrations, the radical 
scavenging activity of the compounds did not 
significantly protect SH-SY5Y cells against 
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